1. Gibson, W. & Wagg, A. Are older women more likely to receive surgical treatment for stress urinary incontinence since the introduction of the mid-urethral sling? An examination of Hospital Episode Statistics data. B.J.O.G. 123, 1386–1392 (2016).
2. Medicines and Healthcare Products Regulatory Agency, MHRA. A summary of the evidence on the benefits and risks of vaginal mesh implants.
https://www.gov.uk/government/publications/vaginal-mesh-implants-summary-of-benefits-and-risks
(2014).
3. Glazener, C.M.A What is the role of mid-urethral slings in the management of stress incontinence in women? [editorial]. Cochrane Database Syst. Rev. 7,
https://doi.org/10.1002/14651858.ED000101
(2015).
4. Dyer, O. Johnson and Johnson faces lawsuit over vaginal mesh devices. B.M.J. 353, i3045 (2016).
5. U.S. Food and Drug Administration, FDA. U.S. Food and Drug Administration Executive Summary: Reclassification of Urogynecologic Surgical Mesh Instrumentation.
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Gastroenterology-UrologyDevicesPanel/UCM487224.pdf
(2016).